Fabrazyme (agalsidase beta)
Billing
Code: J0180
Description: Agalsidase beta injection
Unit: 1 mg
Payment: $208.324
Pay quarter: Q1 2023
Dosage and Frequency
Fabry disease
• 1mg/kg IV every 2 weeks
• 1mg/kg IV every 2 weeks
Calculate drug reimbursement
Total Reimbursement:
$17,665.88(ASP: $16,665.92, Margin: $999.96)
Code:
J0180# Units to bill:
80Prior Authorization
Prior auth criteria for Fabrazyme may include but is not limited to:
Insurance prior auth guidelines:
Billable NDCs
58468-0040-01
Fabrazyme (GENZYME CORPORATION)
35 MG
58468-0041-01
Fabrazyme (GENZYME CORPORATION)
5 MG
Resources